Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

PROVISIONS OF PCR MASTER MIXES - CLONALITY TESTING

Cardiff and Vale University Health Board

This public procurement record has 3 releases in its history.

Award

04 Jun 2026 at 16:22

UK7 - Contract Details Notice
Award

02 Dec 2025 at 14:36

UK6 - Contract Award Notice
Award

02 Dec 2025 at 13:45

UK5 - Transparency Notice
Summary of the contracting process

The Cardiff and Vale University Health Board has completed the procurement process for the "Provisions of PCR Master Mixes – Clonality Testing" contract. The contract is aimed at supplying PCR mastermixes and associated reagents essential for haematological malignancy diagnostics undertaken by The All Wales Medical Genomics Service. This direct award was made to Invivoscribe Technologies SARL, a supplier able to meet the specific technical requirements necessary for continuity of service. This procurement is under the category of laboratory reagents and is applicable region-wide in Wales. The procurement method employed was direct award due to technical constraints, and the contract has been active since 31 March 2026, with a period ending on 31 December 2026.

This tender offers significant opportunities for businesses involved in the manufacture and supply of specialised laboratory reagents. Companies that can deliver high-quality products with robust customer support systems are well-suited to compete in similar tenders. Organisations providing technical expertise and solutions aligned with existing genomic testing frameworks, ensuring minimal disruption and adherence to rigorous standards like UKAS, would find beneficial growth opportunities. As diagnostic services increasingly depend on specialised reagents for disease monitoring and patient care, businesses in this niche can bolster their presence in the public sector by demonstrating capability in meeting specific scientific and operational demands.

How relevant is this notice?

Notice Information

Notice Title

PROVISIONS OF PCR MASTER MIXES - CLONALITY TESTING

Notice Description

The All Wales Medical Genomics Service (AWMGS) is awarding a direct contract for the supply of PCR mastermixes and associated reagents required for B and T cell clonality testing. These assays are critical for diagnosing and monitoring haematological malignancies such as lymphoma and must include validated clonal and polyclonal controls, as well as a control gene, to ensure accurate and reproducible results. In addition to product supply, the contract includes technical support to maintain continuity of service. Changing supplier would require extensive revalidation and re-accreditation of all assays, which would be a major undertaking and cause significant disruption to diagnostic services. This would lead to delays in patient testing, risking late or missed diagnoses and potentially endangering patient health and outcomes. The direct award is therefore essential to safeguard patient safety, maintain compliance with UKAS standards, and ensure uninterrupted delivery of critical genomic testing services across Wales

Procurement Information

The requirement relates to a highly specialised product/service where only a limited number of suppliers in the market can meet the necessary technical and clinical requirements. The selected supplier provides a defined solution that is compatible with existing systems and meets specific performance standards. Due to these technical constraints and the need for continuity of service, no alternative supplier is capable of delivering the required specification without significant disruption or risk

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-05ecf5
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/053014-2026
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
UK7 - Contract Details Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Direct
Procurement Method Details
Direct award
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33696500 - Laboratory reagents

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
£355,550 £100K-£500K
Contracts Value
£108,316 £100K-£500K

Notice Dates

Publication Date
4 Jun 20262 months ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
1 Dec 20258 months ago
Contract Period
31 Mar 2026 - 31 Dec 2026 6-12 months
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Active
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
Cardiff and Vale University Health Board
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
CARDIFF
Postcode
CF14 4HH
Postcode Area
Cardiff
Country
Wales
Major Region (ITL 1)
TLL Wales
Basic Region (ITL 2)
TLL5 South East Wales
Small Region (ITL 3)
TLL52 Cardiff and Vale of Glamorgan
Delivery Location
Not specified
Local Authority
Cardiff
Electoral Ward
Heath
Westminster Constituency
Cardiff North

Supplier Information

Number of Suppliers
1
Supplier Name

Invivoscribe technologies SARL

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...